A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes (NCT07415954)
Efficacy and Safety of Once-weekly Subcutaneous NNC0662-0419 in Participants With Type 2 Diabetes - a Dose-finding Study
🩺 Plain-English Summary (8th-Grade Level)
This study is being done to look at the effect and safety of different doses of NNC0662-0419 in people living with type 2 diabetes when compared to placebo or semaglutide. The purpose of this clinical study is to find out if NNC0662-0419 is effective and safe for treating people living with type 2 diabetes. Participants will get either NNC0662-0419, semaglutide or placebo. Which treatment participants get is decided by chance. NNC0662-0419 is a new medicine which cannot be prescribed by doctors but has previously been tested in humans. Semaglutide is an approved medication to treat type 2 diabetes.
Who can join: Review the eligibility criteria below.
Location: First Valley Medical Group — Lancaster, California
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (63 Sites)
Showing the first 25 of 63 sites.
- First Valley Medical Group — Lancaster, California
- Torrance Clinical Research Institute, Inc. — Lomita, California
- Ark Clinical Research — Long Beach, California
- Pacific Clinical Studies — Los Alamitos, California
- Wetlin Research Associates, Inc. — San Diego, California
- Diablo Clinical Research, Inc. — Walnut Creek, California
- Encore Medical Research LLC — Hollywood, Florida
- Bioclinical Research Alliance — Miami, Florida
- South Broward Research LLC — Miramar, Florida
- West Orange Endocrinology — Ocoee, Florida
- Encore Medical Research of Weston — Weston, Florida
- Elite Clinical Trials — Blackfoot, Idaho
- Cedar-Crosse Research Center — Chicago, Illinois
- Brigham & Women's Hospital — Boston, Massachusetts
- Headlands Research — Springfield, Missouri
- PharmQuest — Greensboro, North Carolina
- Piedmont Healthcare Statesville — Statesville, North Carolina
- Providence Center for Clinical Research — Dayton, Ohio
- CNS Healthcare — Memphis, Tennessee
- University of Texas Southwestern Medical Center — Dallas, Texas
- JCCT- Juno NW Houston — Houston, Texas
- Consano Clinical Research, LLC — Shavano Park, Texas
- Frontier Clinical Research - Kingwood — Kingwood, West Virginia
- Opca bolnica Karlovac — Karlovac,
- Poliklinika SLAVONIJA OSIJEK — Osijek,
📞 Contact the Study Coordinator
Phone: (866) 867-7178
Email: clinicaltrials@novonordisk.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetes Mellitus, Type 2
- Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA — Santa Barbara, California
- Diabetes Discharge Transitional CGM Study (DDT-CGM) — Logan, Utah
- Food Delivery, Remote Monitoring, and Coaching-Enhanced Education for Optimized Diabetes Management (FREEDOM) — Birmingham, Alabama
- MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia — Las Vegas, Nevada
- Strategies to Improve Well-Being and Diabetes Management — Westbrook, Maine
- Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes — Montreal, Quebec
Explore by condition: All Diabetes Mellitus, Type 2 clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.